Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Gynecologic 3Thoracic 2Sarcoma 2Lymphoid 2Gastrointestinal 1

Conditions

Ovarian Neoplasms 3168Uterine Cervical Neoplasms 2191Endometrial Neoplasms 1334Breast Neoplasms 819Fallopian Tube Neoplasms 808Carcinoma, Ovarian Epithelial 772Neoplasms 540Colorectal Neoplasms 439Carcinoma, Non-Small-Cell Lung 420Uterine Cervical Dysplasia 376Pancreatic Neoplasms 363Stomach Neoplasms 354Prostatic Neoplasms 318Lung Neoplasms 315Melanoma 289Uterine Neoplasms 239Peritoneal Neoplasms 238Neoplasm Metastasis 238Vulvar Neoplasms 229Urinary Bladder Neoplasms 225Esophageal Neoplasms 225Head and Neck Neoplasms 222Sarcoma 219Carcinoma, Renal Cell 214Recurrence 213Colonic Neoplasms 210Papillomavirus Infections 206Triple Negative Breast Neoplasms 191Squamous Cell Carcinoma of Head and Neck 177Vaginal Neoplasms 147

Interventions

VGX-3100 1Radiotherapy 1Electroporation Therapies 1Electroporation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
HIV Seropositivity × Gynecologic × Clear all
NCT03603808 2026-05-08

VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions

AIDS Malignancy Consortium

Phase 2 Completed
44 enrolled 15 charts
Gynecologic

Squamous Intraepithelial Lesions, HIV Seropositivity

NCT07167069 2025-09-11

India HIV-CervCa Project

Abramson Cancer Center at Penn Medicine

Active not recruiting
180 enrolled
Gynecologic

Uterine Cervical Neoplasms, HIV Seropositivity

NCT05968183 2023-08-01

PAPILLO-VIH

Centre Hospitalier de Saint-Denis

Unknown
200 enrolled
Gynecologic

Uterine Cervical Neoplasms, HIV Seropositivity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡